Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Appointed director
|
Kintara Therapeutics, Inc. (DMPI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/07/2022 |
SC 13G/A
| Pilkiewicz Carolyn reports a 2.4% stake in Kintara Therapeutics, Inc. |
02/08/2021 |
SC 13G/A
| Pilkiewicz Carolyn reports a 7% stake in Kintara Therapeutics, Inc. |
01/29/2021 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 3.5% stake in Kintara Therapeutics, Inc. |
02/14/2020 |
SC 13G/A
| Anson Funds Management LP reports a 1.5% stake in DelMar Pharmaceuticals, Inc. |
02/11/2020 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.8% stake in DelMar Pharmaceuticals, Inc. |
02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/23/2020 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in DelMar Pharmaceuticals, Inc. |
01/21/2020 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in DelMar Pharmaceuticals, Inc. |
02/08/2019 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 2.5% stake in DelMar Pharmaceuticals, Inc. |
01/25/2019 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 3.1% stake in DelMar Pharmaceuticals, Inc. |
01/07/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/06/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 8.4% stake in DelMar Pharmaceuticals, Inc |
01/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
10/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|